Welcome to our dedicated page for Evolution Global Acquisition C news (Ticker: EVOX), a resource for investors and traders seeking the latest updates and insights on Evolution Global Acquisition C stock.
Evolution Global Acquisition Corp reports developments as a blank-check company formed to pursue a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination. Company news centers on its initial public offering, Nasdaq-listed unit structure, Class A ordinary shares and redeemable warrants.
The SPAC has described a search focus on businesses that own, operate or develop assets in the critical minerals sector. Recurring updates may include capital-structure actions, warrant terms, governance matters and other public-company steps tied to its business-combination mandate.
Evolution Global Acquisition Corp (NASDAQ: EVOX) announced that beginning December 3, 2025 holders of units issued in its November 12, 2025 IPO may elect to separately trade the Class A ordinary shares and warrants on the Nasdaq Global Market.
Each unit consists of one Class A ordinary share and one-half of one redeemable warrant; each whole warrant permits purchase of one Class A ordinary share at an exercise price of $11.50. Separated shares and warrants will trade under EVOX and EVOXW; unsplit units will continue under EVOXU. No fractional warrants will be issued. Shareholders must instruct brokers to contact Continental Stock Transfer & Trust Company, the transfer agent, to effect separation.
EVOLUTION GLOBAL ACQUISITION CORP (EVOX) priced an upsized initial public offering of 21,000,000 units at $10.00 per unit on November 10, 2025, implying gross proceeds of $210 million. Units will trade on Nasdaq as EVOXU beginning November 11, 2025; once separated, shares and warrants are expected to trade as EVOX and EVOXW. Each unit contains one Class A share and one-half warrant; each whole warrant permits purchase of one share at $11.50. The offering is expected to close on November 12, 2025, subject to customary closing conditions, and includes a 45-day underwriter option to buy up to 3,000,000 additional units for over-allotments. The company is a SPAC focused on potential business combinations in the critical minerals sector.